In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute st-elevation myocardial infarction by Noohi, F. et al.
 1- Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, 
Tehran, Iran 
2- Rajaie Cardiovascular Medical and Research Center AND Department of Cardiology, Iran University of Medical Sciences, Tehran, Iran 
Correspondence to: Hamid Reza Sanati, Email: sanati56@yahoo.com 
 
 
 
www.mui.ac.ir 15 January 
  28    ARYA Atheroscler 2016; Volume 12; Issue 1 
In-hospital and six-month outcomes of elderly patients undergoing primary 
percutaneous coronary intervention for acute ST-elevation myocardial infarction 
Fereydoon Noohi(1), Isa Hashemi(2), Hamid Reza Sanati(1),  
Mohammad Mehdi Peighambari(1), Majid Kiavar(1), Mohsen Maadani(1),  
Hossein Ali Bassiri(1), Ali Zahedmehr(1), Farshad Shakerian(1), Ata Firouzi(1),  
Reza Kiani(1), Seifollah Abdi(1) 
 
Abstract 
BACKGROUND: Elderly patients constitute a rapidly growing proportion of the population, and 
hence the increasing rises in the number of patients with ST-segment-elevation myocardial 
infarction (STEMI). Primary percutaneous coronary intervention (PCI), which is now 
established as the preferred reperfusion strategy in STEMI patients, has been inadequately 
investigated in this high-risk group. The aim of the present study was to investigate the in-
hospital and 6-month outcomes of primary PCI in elderly patients (≥ 75 years) with STEMI. 
METHODS: A total of 100 elderly patients with STEMI including those with cardiogenic shock 
were included. Primary PCI procedures were performed in a tertiary referral center between 
2009 and 2014. In-hospital and 6-month outcomes of patients were recorded and analyzed. 
RESULTS: The average age of the patients was 79.6 ± 3.8 years (range = 75-90 years) and 27.0% 
were women. Cardiovascular risk factors and prior events were common. Nearly, half of the 
patients had three-vessel disease and the left anterior descending artery (LAD) was the most 
common infarct-related artery. The presence of cardiogenic shock but not the other variables 
was associated with less anatomic and procedural success (P < 0.001). It was also the major 
independent predictors of 6-month mortality in the patients aged ≥ 75 years, [hazard ratio  
(HR) = 8.02; 95% confidence interval (CI): 1.75-25.97, P < 0.001]. In-hospital mortality was 
2.4% in the patients without and 83.0% in those with cardiogenic shock. 
CONCLUSION: Primary PCI in aged patients could be associated with low complication rates and 
improved survival if performed in high-volume centers with experienced operators. Considering 
the very high rate of mortality in patients with cardiogenic shock, there should be measures to 
treat these patients before the onset of hemodynamic instability. 
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Introduction 
Population growth and advanced health care have 
conferred an increase in life expectancy among 
elderly patients. It is predicted that the proportion 
of octogenarians will probably have tripled by the 
year 2050.1 Coronary artery diseases (CADs) and its 
associated acute events such as ST-segment-
elevation myocardial infarction (STEMI) are very 
frequent in the aged population and cause 
significant morbidity and mortality. Primary 
percutaneous coronary intervention (PCI) is 
currently the method of choice and the best 
reperfusion strategy for patients presenting with 
STEMI in that it has reduced the rates of cardiac 
mortality and re-infarction over the last decades.2,3 
Even though elderly patients constitute a major 
high-risk population of patients with STEMI who 
might benefit from more invasive therapies, they are 
frequently excluded from clinical trials owing to 
higher morbidity and mortality associated with the 
primary PCI.4 Worse outcome is influenced not 
only by the extensive CAD but also by more 
complex comorbidities.5 In addition, elderly patients 
are more likely to suffer from complications 
following revascularization procedures.6 The 
existing literature contains no research on the 
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outcome of primary PCI in elderly Iranian patients. 
We, therefore, sought to evaluate the in-hospital 
and mid-term outcomes of primary PCI in patients 
aged ≥ 75 years old, who presented with acute 
STEMI in a high-volume tertiary center. 
Materials and Methods 
A retrospective evaluation of the primary PCI 
database was performed between April 2009 and 
May 2014. The local Ethics Committee of Rajaie 
Cardiovascular, Medical and Research Center, Iran 
University of Medical Sciences, Tehran, Iran, 
approved the trial design. 
A total of 656 primary PCI-treated patients were 
initially evaluated. The inclusion criteria were 
comprised age > 75 years and chest pain 
accompanied by ST-segment-elevation in at least 
two contagious leads presenting within the first 12 
hours after the symptom onset or after 12 hours in 
the case of persistent chest pain. Notably, patients 
with hemodynamic instability or cardiogenic shock 
at the time of presentation or during the hospital 
course were not excluded from the study. 
Cardiogenic shock patients were considered eligible 
if they presented within 36 hours after the initiation 
of chest pain and no more than 18 hours after the 
development of shock. Patients with inability to 
receive dual antiplatelet therapy, the presence of the 
left main involvement, severe CAD or mechanical 
complications of MI requiring surgical intervention 
and extreme comorbidities precluding primary PCI 
as a therapeutic option were excluded. Finally, a 
total of 100 consecutive elderly patients were 
selected and analyzed.  
The study patients received the same routine 
preparation protocol for coronary angiography and 
primary PCI, including 325 mg of the loading dose 
of aspirin and 300-600 mg of the loading dose of 
clopidogrel before the procedure. Primary PCI 
procedures were performed via routine standards by 
an experienced team. The intention to treat was for 
culprit lesions, and multivessel PCI was performed 
in cardiogenic shock patients who were 
unresponsive to the culprit PCI. The in-hospital and 
6-month clinical outcomes of the patients were 
recorded using the hospital data registry, patients’ 
files, and telephone calls. Anatomical success was 
defined as the attainment of a residual diameter 
stenosis < 20% and normal epicardial flow based 
on thrombolysis in myocardial infarction grading 
(TIMI-3 flow). Procedural success was considered 
as anatomical success without the occurrence of 
major complications (i.e. death, MI, or urgent 
revascularization) during the hospital course. 
Statistical analysis was performed using SPSS 
software (version 16, SPSS Inc., Chicago, IL, USA). 
The results are presented as means ± standard 
deviation (SD) for the continuous variables and as 
percentages for the categorical data. The chi-square 
test was used to compare the numerical variables.  
6-month cumulative survival rates were assessed 
with the Kaplan-Meier curve. Cox regression model 
was implemented to determinate the independent 
predictors of 6-month cumulative mortality and 
clinical success. A P <0.050 was considered  
a significant. 
Results 
About 100 primary PCI patients over the age of 75 
were included. The average age of the patients was 
79.6 ± 3.8 years (range = 75-90 years) and 27% 
were women. The baseline clinical characteristics of 
the study patients are summarized in table 1. 
Hypertension was the most common risk factor 
(53%), and 74% of the cases had, at least, one of the 
four known risk factors for atherosclerosis. 18% of 
the patients presented with or developed 
cardiogenic shock on admission or during the 
hospital course. Previous cardiovascular events and 
interventions were also fairly common. The 
procedural angiographic and interventional 
characteristics of the patients are depicted in  
table 2.  
 
Table 1. Baseline characteristics of the patients 
100 patients Prevalence 
Age (year) (mean ± SD) 79.60 ± 3.86 
Sex (%)  
Male 73 
Female 27 
Risk factors (%)  
Smoking 18 
Hypertension 53 
Dyslipidemia 30 
Diabetes 37 
Past medical history (%)  
MI 31 
PCI 13 
CABG 4 
CVA 6 
CKD 8 
Cardiogenic shock (%) 18 
MI: Myocardial infarction; PCI: Percutaneous coronary 
intervention; CABG: Coronary artery bypass grafting;  
CVA: Cerebrovascular accident; CKD: Chronic kidney 
disease; SD: Standard deviation 
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Table 2. Angiographic and procedural data 
Variables Prevalence (%) 
Disease extension  
Single-vessel disease 25 
Two-vessel disease 28 
Three-vessel disease 47 
Infarct-related artery  
LAD 50 
RCA 33 
LCX 14 
Venous graft 3 
Post-procedural TIMI flow  
III 73 
II 17 
0-I 10 
LAD: Left anterior descending artery; RCA: Right coronary 
artery; LCX: Left circumflex artery; TIMI flow: 
Thrombolysis in myocardial infarction 
 
The involvement of more than one coronary 
vessel was common, and 47% of the cases were 
diagnosed to have three-vessel disease. The left 
anterior descending artery (LAD) was the most 
common infarct-related artery, followed by the right 
coronary artery (RCA) (50 and 33%, respectively). 
Anatomical success was achieved in 73% of the 
patients. The no-reflow phenomenon (TIMI-0 and 
TIMI-1) occurred in 10% of the study population 
and the slow flow (TIMI-2) in 17%. Age, presence 
of risk factors and baseline morbidities were not 
associated with the occurrence of the no-
reflow/slow flow phenomenon. This was also the 
case for the extension of the vessel involvement and 
the culprit artery (Table 3). However, there was a 
meaningful association between the anatomical 
success rate and the presence of cardiogenic shock 
(P < 0.001). Cardiogenic shock was also the sole 
parameter significantly associated with less 
procedural success. Neither the number of the 
diseased vessels nor a specific culprit artery had a 
significant influence on the procedural success rates. 
The mean duration of hospital stay was 6.3 ± 3.0 
days in those discharged alive (range = 2-17 days).  
The rate of in-hospital mortality was 17%:  
2 (2.4%) cases in the patients without cardiogenic 
shock and 15 (83%) cases in those with cardiogenic 
shock. The presence of cardiogenic shock was 
significantly associated with the occurrence of death 
during hospitalization (P < 0.001). The probability 
of being free from the occurrence of death was 
investigated via Kaplan-Meier method which 
presented in figure 1. The in-hospital and 6-month 
adverse events are shown in table 4. In a multiple 
cox regression model, cardiogenic shock [hazard 
ratio (HR): 8.02, 95% confidence interval (CI): 1.75-
25.97; P < 0.001], anatomical success rate (HR: 6.7, 
95% CI: 1.16-22.7; P < 0.001), and post-procedural 
stroke (HR: 3.01, 95% CI: 1.01-7.6; P = 0.026) were 
identified as the independent predictors of mortality 
during the follow-up. 
Discussion 
Elderly people are the most rapidly growing 
proportion of the world population, and acute MI 
is the leading cause of cardiac death in this group. 
Despite the extensive implementation of 
mechanical reperfusion therapy, it may be difficult 
to choose the best reperfusion strategy for elderly 
patients, who are more likely to have additional 
comorbidities and risk factors. Although most 
studies have shown the relative superiority of 
primary PCI over the other reperfusion strategies 
or no reperfusion, there are several important 
factors which limit the widespread use of the 
former in elderly patients. Elderly patients with 
acute MI are less often treated with reperfusion 
therapy than younger patients.7 These patients 
frequently present late after the initiation of MI 
because of atypical symptoms, impaired pain 
perception, and delays relating to the family 
members and health care system. It is also worth 
bearing in mind that even if primary PCI is 
performed, it is associated with high rates of early 
and late complications and limited survival.8 
Meanwhile, it has been shown that reperfusion 
therapy, compared with conservative therapies, has 
significantly reduced 30-day and 1-year mortality 
rates in elderly acute MI patients.9-12 Another reason 
that renders arriving at a final conclusion complex is 
that elderly patients with acute MI are frequently 
excluded from randomized clinical trials.13 By 
comparison with similar studies, ours showed a 
large proportion of male patients treated with 
primary PCI. The difference may be due to ethnic 
differences and the exclusion of the aged and 
perhaps more disable women from invasive 
strategy. The elderly patients in the present study 
had multiple risk factors and advanced CAD; 
however, primary PCI was associated with an 
acceptable anatomical and procedural success rates. 
In addition, the in-hospital mortality rate was 
considerably low and comparable with that of the 
younger patients. In those who survived the 
hospital course, 6-month follow-up also showed 
improved survival and an event-free course, 
underscoring once again the importance of the 
timely application of primary PCI in this  
high-risk group.  
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Table 3. Anatomical and procedural success rates 
Variable Anatomical success rate (%) P Procedural success rate (%) P 
Sex  0.880  0.780 
Male 72.6 56.2 
Female 74.1 59.3 
Diabetes  0.990  0.380 
Yes 73.0 51.4 
No 73.0 60.3 
Hypertension  0.880  0.190 
Yes 73.6 50.9 
No 72.3 63.8 
Hyperlipidemia  0.590  0.690 
Yes 76.7 60.0 
No 71.4 55.7 
Smoking  0.270  0.890 
Yes 83.3 55.6 
No 70.7 57.3 
Prior CABG  0.920  0.770 
Yes 75.0 50.0 
No 72.9 57.3 
Prior PCI  0.310  0.120 
Yes 84.6 76.9 
No 71.3 54.0 
Prior MI  0.750  0.770 
Yes 71.0 54.8 
No 73.9 58.0 
Prior CVA  0.550  0.720 
Yes 83.3 50.0 
No 72.3 57.4 
CKD  0.330  0.240 
Yes 87.5 37.5 
No 71.7 58.7 
Disease extension  0.950  0.760 
Single-vessel disease 72.0 60.0 
Two-vessel disease 71.4 60.6 
Three-vessel disease 74.5 53.2 
Culprit artery  0.500  0.610 
LAD 68.0 52.0 
RCA 78.8 57.6 
LCX 71.4 71.4 
Venous graft 100 66.7 
Cardiogenic shock  < 0.001  < 0.001 
Yes 27.8 11.1 
No 82.9 67.1 
All the associations were assessed via Pearson’s chi-square test. P < 0.050 considered as statistically significant. 
CABG: Coronary artery bypass grafting; PCI: Percutaneous coronary intervention; MI: Myocardial infarction; CVA: Cerebrovascular 
accident; CKD: Chronic kidney disease; LAD: Left anterior descending artery; RCA: Right coronary artery; LCX: Left circumflex artery 
 
The SHOCK trial (SHould we emergently 
revascularize Occluded Coronaries in cardiogenic 
shocK) found no benefit with revascularization in 
patients over 75 years of age complicated by 
cardiogenic shock; nevertheless, several large 
observational studies have shown the advantages of 
early revascularization in the elderly with 
cardiogenic shock.14-17 There are also studies 
revealing extremely high mortality rates in patients 
aged > 75 years with cardiogenic shock even with 
the early interventional approach. In the Zeymer  
et al.18 registry, 63% of the patients older than 75 
years died. In our study, the cardiogenic shock was 
the most powerful independent risk factor for poor 
anatomical and procedural success and finally death 
following primary PCI. The high mortality rate in 
our elderly patients with cardiogenic shock might 
have additional reasons. Our hospital is a tertiary 
center and, as such, the majority of its patients are 
referred from other hospitals quite late after the 
initiation of chest pain or just after the occurrence 
of cardiogenic shock. In addition, apart from the 
intra-aortic balloon pump, no other supportive 
circulatory device was used in our patients. 
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Table 4. Short- and long-term adverse events 
Variables Without shock (n = 82) With shock (n = 18) P 
Hospital stay (days) 6.6 17.3 0.001* 
Major bleeding [n (%)]    
In-hospital 2 (2.4) 0 (0) 0.500 
6-month 0 (0) 0 (0) - 
CVA [n (%)]    
In-hospital 0 (0) 1 (5.6) 0.480** 
6-month 2 (2.5) 0 (0) 0.510** 
MI [n (%)]    
In-hospital 2 (2.4) 6 (33) 0.100** 
6-month 0 (0) 2 (67) 0.430** 
Stent thrombosis [n (%)]    
In-hospital 2 (2.4) 0 (0) 0.500** 
6-month 0 (0) 0 (0) - 
Mortality [n (%)]    
In-hospital 2 (2.4) 15 (83) < 0.001** 
6-month 0 (0) 1 (33) 0.330** 
CVA: Cerebrovascular accident; MI: Myocardial infarction 
*Student’s t-test, **Pearson’s chi-square test 
 
 
Figure 1. Kaplan-Meier estimate of cumulative in-hospital and 6-month 
survival rates 
 
Limitations 
First and foremost among the limitations of the 
present study is that it is not sufficiently powered 
because of the small number of the participants. 
Another shortcoming is that the results of this 
single referral Centre study may have been 
influenced by patient selection biases. Our treated 
patients probably had a high-risk profile compared 
with the real world presentation of patients with 
acute MI. 
Conclusion 
It is widely accepted that primary PCI in the elderly 
is more challenging, and future prospective studies 
in the elderly with STEMI are needed to evaluate 
the effectiveness and safety of primary PCI in this 
patient population.19 Our study showed that 
primary PCI in aged patients could be associated 
with low complication rates and improved survival 
if performed in high-volume centers with 
experienced operators. Given the very high rate of 
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mortality in patients with cardiogenic shock, there 
should be measures to treat these patients before 
the onset of hemodynamic instability. 
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